Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry
Results 2041 - 500 out of 500 displayed.
« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
Reset ↻

Sig Kirk Joins Assertio Board of Directors

Read more ››

By: GlobeNewswire - 03 Apr 2024

Related companies: Assertio Holdings, Inc.

Aligos Therapeutics Announces First Subjects Dosed in the Phase 2a HERALD Study of ALG-055009 in MASH Subjects

Read more ››

By: GlobeNewswire - 03 Apr 2024

Related companies: Aligos Therapeutics, Inc.

BrightInsight Named to Forbes 2024 List of America's Best Startup Employers

Read more ››

By: GlobeNewswire - 03 Apr 2024

Related companies: BrightInsight, Inc.

BetterLife Announces Closing of $1.168 Million Convertible Debentures to Further Advance IND-enabling Studies of its Non-hallucinogenic LSD-based Drug Candidate BETR-001

Read more ››

By: GlobeNewswire - 03 Apr 2024

Related companies: BetterLife Pharma Inc.

Black Diamond Therapeutics to Participate in Upcoming Investor Conferences

Read more ››

By: GlobeNewswire - 03 Apr 2024

Related companies: Black Diamond Therapeutics Inc.

TRACON Pharmaceuticals Provides Update on Ongoing ENVASARC Phase 2 Pivotal Trial Following Independent Data Monitoring Committee Recommendation to Continue the Trial as Planned

Read more ››

By: GlobeNewswire - 03 Apr 2024

Related companies: TRACON Pharmaceuticals, Inc.

Redhook Brewery Announces New “Big Juicy Ballard” IPA and Revives IPA Daze Festival at the Brewlab on 4/20 Weekend

Read more ››

By: GlobeNewswire - 03 Apr 2024

Related companies: Tilray Inc.

Fate Therapeutics to Present at 23rd Annual Needham Virtual Healthcare Conference

Read more ››

By: GlobeNewswire - 03 Apr 2024

Related companies: Fate Therapeutics, Inc.

Lexicon Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Read more ››

By: GlobeNewswire - 03 Apr 2024

Related companies: Lexicon Pharmaceuticals, Inc.

Milestone® Pharmaceuticals to Present at the 23rd Annual Needham Healthcare Conference

Read more ››

By: GlobeNewswire - 03 Apr 2024

Related companies: Milestone Pharmaceuticals Inc.

Apnimed to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Read more ››

By: GlobeNewswire - 03 Apr 2024

Related companies: Apnimed, Inc.

iCAD Partners with RAD-AID to Advance Breast Cancer Detection Using AI in Underserved Regions and Low- and Middle-Income Countries (LMICs)

Read more ››

By: GlobeNewswire - 03 Apr 2024

Related companies: iCAD, Inc.

FeraMAX® Named #1 Recommended Iron Supplement in Canada by Pharmacists and Physicians for Ninth Consecutive Year

Read more ››

By: GlobeNewswire - 03 Apr 2024

Related companies: BioSyent Inc.

CRISPR Therapeutics to Present at the Annual Needham Virtual Healthcare Conference

Read more ››

By: GlobeNewswire - 03 Apr 2024

Related companies: CRISPR Therapeutics AG

American Oncology Network Expands to Hawaii, Welcomes New Practice to Network

Read more ››

By: GlobeNewswire - 03 Apr 2024

Related companies: American Oncology Network, LLC

Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in Europe

Read more ››

By: GlobeNewswire - 03 Apr 2024

Related companies: Amarin Corporation plc

Phathom Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Read more ››

By: GlobeNewswire - 03 Apr 2024

Related companies: Phathom Pharmaceuticals, Inc.

Lipella Pharmaceuticals Announces FDA Type C Meeting for LP-10 for Hemorrhagic Cystitis

Read more ››

By: GlobeNewswire - 03 Apr 2024

Related companies: Lipella Pharmaceuticals Inc.

CytomX Therapeutics Announces Nomination of Second Clinical Candidate in Broad PROBODY® T-Cell Engaging Bispecific (TCB) Collaboration with Astellas

Read more ››

By: GlobeNewswire - 03 Apr 2024

Related companies: CytomX Therapeutics, Inc.

Tevogen Bio Appoints Tapan V Shah as Head of Investor Relations and Corporate Development

Read more ››

By: GlobeNewswire - 03 Apr 2024

« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

to the top ↑